Form 4: PHLT CFO's Planned Stock Transactions

Performant Healthcare's CFO, Rohit Ramchandani, reported planned acquisitions of common stock from RSU vesting and subsequent dispositions for tax liabilities.

Summary

• Rohit Ramchandani, Chief Financial Officer of Performant Healthcare Inc. (PHLT), reported planned transactions involving the company's common stock.
• On August 11, 2025, Ramchandani is set to acquire 23,162 shares of common stock through the exercise/conversion of Restricted Stock Units (RSUs) at a price of $0.00 per share.
• Concurrently, 11,531 shares are planned to be disposed of at $7.63 per share to cover tax liabilities associated with the RSU vesting.
• An additional 16,267 shares are planned to be acquired from another RSU vesting event at $0.00 per share.
• Following this, 8,098 shares are planned to be disposed of at $7.63 per share to cover tax liabilities for this second RSU vesting.
• The RSUs were awarded at no cost and represent a contingent right to receive one share of common stock.
• The first RSU award was granted on August 8, 2022, and vests in four equal installments on anniversaries of the grant date.
• The second RSU award was granted on August 5, 2024, and also vests in four equal installments on anniversaries of the grant date.
• After these planned transactions, Ramchandani's direct beneficial ownership of common stock is expected to be 253,315 shares.
• The filing indicates these transactions are made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: The filing reports routine, pre-scheduled insider transactions related to equity compensation. It is neutral in sentiment as it reflects standard compensation practices rather than new strategic developments or financial performance.

Positives

• Chief Financial Officer Rohit Ramchandani is acquiring a total of 39,429 shares (23,162 + 16,267) of common stock through the vesting of Restricted Stock Units at no cost, indicating continued equity participation.
• The transactions are part of a pre-arranged Rule 10b5-1 plan, which demonstrates a structured approach to insider trading and reduces concerns about opportunistic selling.

Negatives

• A total of 19,629 shares (11,531 + 8,098) are planned to be disposed of at $7.63 per share to cover tax liabilities, which represents a reduction in direct beneficial ownership.

Future Outlook

The filing details pre-scheduled equity transactions under a Rule 10b5-1 plan, indicating future vesting and tax-related share dispositions for the Chief Financial Officer on August 11, 2025.

Industry Context

This filing is a routine insider transaction report, common across all industries for publicly traded companies, reflecting standard equity compensation practices for executives. It does not provide broader industry trends or competitive insights.

Related Party Transactions

• The filing details transactions between the company (Performant Healthcare Inc.) and its Chief Financial Officer, Rohit Ramchandani, which are inherently related-party dealings in the context of executive compensation and stock ownership.

Stakeholder Impact

• Shareholders: The transactions represent a routine part of executive compensation, with the CFO acquiring shares through vesting and selling a portion for tax purposes. This is a common practice and generally has minimal direct impact on share price unless the volume is unusually large or the transactions are discretionary sales.
• Employees: The filing highlights the company's use of Restricted Stock Units as a form of equity compensation, which is a common practice that can align executive incentives with shareholder interests.

Next Steps

• The reported transactions are scheduled to occur on August 11, 2025, as part of the pre-arranged Rule 10b5-1 plan.

Key Dates

Recommendation

This Form 4 filing details routine, pre-scheduled insider transactions related to the vesting of Restricted Stock Units and subsequent tax-related sales by the Chief Financial Officer. Such transactions are a standard part of executive compensation and do not typically indicate a change in the company's fundamental outlook or performance. Therefore, it provides no new information that would warrant a change in investment recommendation; a 'hold' stance is appropriate based solely on this filing.

Keywords

Performant Healthcare, PHLT, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Stock Compensation, CFO, Rohit Ramchandani, Equity Compensation, 10b5-1 Plan